Not Yet Recruiting
Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)
NCT07173933
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Peking Union Medical College Beijing, China